Metamizol-Mepha 500 mg, Tablette - 50 Swissmedic Key 66998002 Registration Holder Mepha Pharma AG Name Metamizol-Mepha 500 mg, Tablette Date of registration 18.12.2018 Original/Generic Generic Introduction of Sequence 18.12.2018 ATC-Classification Metamizole Sodium (N02BB02) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 01.01.10. Show package size 50 Index Therapeuticus (Swissmedic) 01.01.10. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 2.43 Limitation No Deductible 10 % Consumer price 11.90 Feedback FB Daily cost GTIN 7680669980023 Medication Code Synthetika Pharmacode 7754963 Disponibility
Composition metamizolum natricum monohydricum 500 mg, amylum pregelificatum, macrogolum 6000, crospovidonum, magnesii stearas, silica colloidalis anhydrica, pro compresso. Packungsbestandteile Galenic Form Tablette Active Agent Dose Metamizolum Natricum Monohydricum 500 mg
BAG: Active Agent Dose Metamizolum Natricum Monohydricum 500 mg
Inactive agents Dose Amylum Pregelificatum Crospovidonum Macrogol 6000 Magnesii Stearas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 04.04.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
